Biogen (NASDAQ:BIIB) will collaborate with privately held Skyhawk Therapeutics to discover novel small molecules for neurological diseases based ... read more
Biogen teams up with Skyhawk Therapeutics in neurological diseases
Biogen teams up with Skyhawk Therapeutics in neurological diseases